- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Cost-related Medication Non-adherence Among US Adults: Unveiling Insights from NCHS Data Brief
A new data brief from the NCHS examined the characteristics of US adults who did not take medication as prescribed to reduce costs. A breakdown of the results, here.
Rising out-of-pocket costs on prescription medications may limit patients' access to medications and lead them to not take them as prescribed by their clinician to save money. A new data brief from the National Center for Health Statistics (NCHS) shows that in 2021, 8.2% of US adults who took prescription medication in the past 12 months reported not taking it as prescribed in order to reduce costs. Authors of the NCHS brief used data from the 2021 National Health Interview Survey to examine the characteristics of adults aged 18–64 years who took prescription medication in the past 12 months and did not take medication as prescribed due to cost. Cost-saving measures included skipping doses, taking less medication than was prescribed, or delaying filling a prescription.
A breakdown of the findings by age, sex, race, health status, family income, health insurance coverage, and more in the slides below.
FDA Approves First Oral GLP-1 Receptor Agonist for Chronic Weight Management
December 23rd 2025The FDA approved once-daily oral semaglutide 25 mg for chronic weight management and long-term weight maintenance in adults with obesity or overweight, based on data from the OASIS clinical trial program.
Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1–Based Weight Loss
December 19th 2025Topline Phase 3 ATTAIN-MAINTAIN data show oral orforglipron met primary and key secondary endpoints for weight maintenance after prior GLP-1–based injectable therapy in adults with obesity.
